The structure of the so-called liquid-ordered (lo) phase of binary mixtures of DPPC-d(62) with cholesterol was studied between 20-50 mol% cholesterol using (2)H-NMR, FT-IR, DSC, and neutron specular reflection. Different model systems such as multilamellar vesicles, spherical supported vesicles, and oriented multilayers were used. We observed significant changes of the lo phase structure in the physiological relevant temperature region between 30-45 degrees C. (2)H-NMR in combination with lineshape simulations provides evidence for a drastic effect of cholesterol on the shape of multilamellar vesicles due to magnetic field orientation. Moreover, the data indicates a significant change of the extent of this partial orientation for DPPC-d(62) multilamellar vesicles containing 25 mol% cholesterol between 36-42 degrees C. The semiaxes ratio of the (due to magnetic field orientation) ellipsoidal multilamellar vesicles changes over this temperature range by approximately 25%. (2)H-NMR and FT-IR measurements indicate changes of the average orientational order at the bilayer center in the same temperature range and a significant increase of the number of end-gauche conformers while the majority of the methylene groups remain in an all-trans conformation. Additionally, specular reflection of neutrons shows a concomitant reduction of the bilayer thickness by 4 A. Based on a model of the arrangement of DPPC and cholesterol in the lo phase, a molecular mechanism is proposed in which increasing the temperature between 30 and 45 degrees C has the effect of driving cholesterol from the bilayer center towards the head group region.

The transfer of lipids between small unilamellar vesicles of either dimyristoylphosphatidylcholine (DMPC), dimyristoylphosphatidylglycerol (DMPG), or dioctadecyl diammonium bromide (DODAB) and a single bilayer on a solid support of chain perdeuterated DMPC-d54 has been studied by time-resolved ATR infrared spectroscopy, deuterium NMR, and DSC. The IR method was used for measuring the transfer kinetics and the amount of lipid transferred to the supported bilayer, while NMR was employed for the assessment of molecular order and for the occurrence of lipid asymmetries due to the transfer. We find that the composition of a supported planar dimyristoylphosphatidylcholine (DMPC-d54) bilayer can be modified by incubation with high concentrations of sonicated vesicles consisting of the donor lipid. Three cases were studied. First, the incubation was done with DMPC as donor lipid. The kinetics of this process is double exponential and comparatively slow, with a half-time in the range of several hours. The activation energy was estimated as 50 +/- 2 kJ/mol. In a second set of measurements, cationic DODAB or anionic DMPG was used as donor lipid. The kinetics of this transfer is 1 order of magnitude faster than for DMPC and can be described by a single exponential. For DMPG transfer, we obtained an activation energy of 35 +/- 2 kJ/mol. Independent of the headgroup charge of the donor lipid, 25-35% of the (acceptor) DMPC in the supported bilayer is not accessible for exchange with the donor lipid. The transfer of either DMPG or DODAB causes drastic changes of the phase transition behavior of the supported bilayer without significantly altering the lipid packing density of the lipids.(ABSTRACT TRUNCATED AT 250 WORDS)

The purpose of this study was to characterize T 1 , particularly in the hyperthermia temperature range (ca. 37-44°C), in order to control regional hyperthermia with MR monitoring using 0.

MR-thermometry methods have been developed for the guidance and control of thermal therapies such as thermal ablation or regional hyperthermia. However, they are limited to the measurement of temperature changes and, thus, cannot be used to assess absolute temperature values. Paramagnetic thermosensitive liposomes are innovative contrast agents offering the potential to overcome these limitations. They are composed of a gadolinium- or manganese-based compound enclosed by a phospholipid membrane with a distinct gel-to-liquid crystalline phase transition temperature (Tm). At this temperature, the phospholipid membrane changes from a gel-phase to a liquid-crystalline phase which is associated with an increased transmembrane permeability towards solutes and water. Under these conditions, both types of paramagnetic thermosensitive liposomes demonstrate a significant increase in longitudinal (T1) relaxivity, attributed to the release of paramagnetic material from the liposome and/or to the increased water exchange rate between the liposome interior and exterior. Paramagnetic thermosensitive liposomes have already been successfully studied in animal models and have demonstrated a clear correlation between tissue temperature changes and signal intensity changes in MRI. Nevertheless, before entering clinical trials they have to be studied in more detail with regard to dose, pharmacokinetics and toxicity.

Thermosensitive liposomes (TSL) with encapsulated proton (1H) magnetic resonance (MR) contrast agents have been proposed for noninvasive online temperature monitoring during tumor treatment using chemotherapy combined with hyperthermia (HT). The technique exploits the fact that water exchange between the TSL interior and exterior is increased and/or the encapsulated 1H MR contrast agent is released near the gel-to-liquid crystalline phase transition temperature (Tm) of TSL and thus shortens the 1H MR relaxation time of tissue. In this work, newly developed, phosphatidylglyceroglycerol (DPPGOG)-based TSL with encapsulated 1H MR longitudinal relaxation time (T1)-shortening gadodiamide (Gd-DTPA-BMA) were characterized in vitro by measuring the temperature dependence of the T1 of these gadodiamide-containing DPPGOG-TSL samples between 30 and 50 degrees C. The measurements revealed that the T1 nonlinearly slightly decreased with increasing temperature from 30 to 37 degrees C, mainly due to increased water exchange between the gadodiamide-containing DPPGOG-TSL interior and exterior with the exception of negligible gadodiamide release. This implies that gadodiamide-containing DPPGOG-TSL were stable at temperatures < or =37 degrees C, which was also confirmed by an independent stability study. From 37 to 44 degrees C, the T1 nonlinearly markedly decreased with increasing temperature since encapsulated gadodiamide was rapidly released. Above 44 degrees C, gadodiamide was completely released and the T1 was directly proportional to temperature while heated from 44 to 50 degrees C and cooled from 50 to 30 degrees C, respectively. Additionally, gadodiamide release was theoretically quantified and this calculated concentration was consistent with the actually released amount directly obtained from the cooling course of empty DPPGOG-TSL with completely released gadodiamide.